➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson
McKinsey
AstraZeneca

Last Updated: September 26, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077869


Email this page to a colleague

« Back to Dashboard

NDA 077869 describes ZONISAMIDE, which is a drug marketed by Ani Pharms, Apotex Inc, Aurobindo Pharma Ltd, Bionpharma Inc, Cadila, Epic Pharma Llc, Glenmark Generics, Granules, Heritage Pharma, Invagen Pharms, Mylan, Mylan Pharms Inc, Roxane, Sun Pharm Inds (in), Sun Pharm Industries, Unichem, and Upsher Smith Labs, and is included in eighteen NDAs. It is available from twenty suppliers. Additional details are available on the ZONISAMIDE profile page.

The generic ingredient in ZONISAMIDE is zonisamide. There are nineteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the zonisamide profile page.
Summary for 077869
Tradename:ZONISAMIDE
Applicant:Invagen Pharms
Ingredient:zonisamide
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 077869
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZONISAMIDE zonisamide CAPSULE;ORAL 077869 ANDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-8266 0615-8266-39 30 CAPSULE in 1 BLISTER PACK (0615-8266-39)
ZONISAMIDE zonisamide CAPSULE;ORAL 077869 ANDA AvPAK 50268-816 50268-816-15 50 BLISTER PACK in 1 BOX (50268-816-15) > 1 CAPSULE in 1 BLISTER PACK (50268-816-11)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength25MG
Approval Date:May 31, 2006TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength50MG
Approval Date:May 31, 2006TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:May 31, 2006TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Moodys
Johnson and Johnson
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.